Literature DB >> 17570945

Cellular and molecular mechanisms of proteinuria in diabetic nephropathy.

Gunter Wolf1, Fuad N Ziyadeh.   

Abstract

One of the earliest clinically detectable abnormalities in diabetic nephropathy is microalbuminuria that eventually progresses to proteinuria. The degree of proteinuria correlates with the progression of glomerulosclerosis and tubulointerstitial fibrosis. In the glomerulus, a typical podocytopathy develops that participates in the initiation of glomerulosclerosis and the accelerated plasma protein leakage across the glomerular basement membrane (GBM) into Bowman's space. Downstream into the tubular compartment, the proteinuria induces proinflammatory and profibrogenetic injury in tubular cells which can facilitate the development of interstitial fibrosis and tubular atrophy. It has long been held that hemodynamic changes and the loss of negatively charged proteoglycans in the GBM are important mediators of proteinuria. More recently, biopsy studies in humans with diabetic kidney disease have provided strong evidence that podocytes are injured very early in the course of nephropathy. This podocytopathy--which is characterized by decreased podocyte number and/or density, GBM thickening and altered matrix composition, and foot process effacement--correlates closely with the development and progression of albuminuria. Components of the diabetic milieu (high glucose, accumulation of glycated proteins, high intrarenal angiotensin II (ANG II), and hypertension-induced mechanical stress) result in activation of cytokine systems, the most important of which are transforming growth factor-beta1 (TGF-beta1) and vascular endothelial growth factor-A (VEGF-A). ANG II-stimulated podocyte-derived VEGF, through a novel autocrine signaling loop, appears to be a major cause of nephrin downregulation and the development of proteinuria. Nephrin is an important protein of the slit diaphragm with anti-apoptotic signaling properties. TGF-beta1 causes podocyte apoptosis and an increase in extracellular matrix deposition. As a consequence, the denuded GBM adheres to Bowman's capsule initiating the development of glomerulosclerosis. Good control of hyperglycemia and hypertension and maximal inhibition of ANG II are essential steps in preventing the development and progression of diabetic nephropathy. Copyright 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2007        PMID: 17570945     DOI: 10.1159/000101797

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  79 in total

1.  Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria.

Authors:  Chunsun Dai; Moin A Saleem; Lawrence B Holzman; Peter Mathieson; Youhua Liu
Journal:  Kidney Int       Date:  2010-03-10       Impact factor: 10.612

2.  TGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.

Authors:  Sung Il Kim; So-Young Lee; Zhibo Wang; Yan Ding; Nadeem Haque; Jiwang Zhang; Jing Zhou; Mary E Choi
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

3.  Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions.

Authors:  K Nobe; Y Nezu; N Tsumita; T Hashimoto; K Honda
Journal:  Br J Pharmacol       Date:  2008-09-22       Impact factor: 8.739

4.  Podocyte vascular endothelial growth factor (Vegf₁₆₄) overexpression causes severe nodular glomerulosclerosis in a mouse model of type 1 diabetes.

Authors:  D Veron; C A Bertuccio; A Marlier; K Reidy; A M Garcia; J Jimenez; H Velazquez; M Kashgarian; G W Moeckel; A Tufro
Journal:  Diabetologia       Date:  2011-02-12       Impact factor: 10.122

5.  AT1R blockade in adverse milieus: role of SMRT and corepressor complexes.

Authors:  Tejinder Singh; Kamesh Ayasolla; Partab Rai; Nirupama Chandel; Shabirul Haque; Rivka Lederman; Mohammad Husain; Vasupradha Vethantham; Amrita Chawla; Himanshu Vashistha; Moin A Saleem; Guohua Ding; Praveen N Chander; Ashwani Malhotra; Leonard G Meggs; Pravin C Singhal
Journal:  Am J Physiol Renal Physiol       Date:  2015-06-17

6.  Decorin deficiency in diabetic mice: aggravation of nephropathy due to overexpression of profibrotic factors, enhanced apoptosis and mononuclear cell infiltration.

Authors:  R Merline; S Lazaroski; A Babelova; W Tsalastra-Greul; J Pfeilschifter; K D Schluter; A Gunther; R V Iozzo; R M Schaefer; L Schaefer
Journal:  J Physiol Pharmacol       Date:  2009-10       Impact factor: 3.011

7.  Heterozygous knockout of transforming growth factor-β1 protects Dahl S rats against high salt-induced renal injury.

Authors:  Chun Cheng Andy Chen; Aron M Geurts; Howard J Jacob; Fan Fan; Richard J Roman
Journal:  Physiol Genomics       Date:  2012-12-18       Impact factor: 3.107

8.  The manganese superoxide dismutase Val16Ala polymorphism is associated with decreased risk of diabetic nephropathy in Chinese patients with type 2 diabetes.

Authors:  Limei Liu; Taishan Zheng; Niansong Wang; Feng Wang; Ming Li; Jiamei Jiang; Ruie Zhao; Lifang Li; Weijing Zhao; Qihan Zhu; Weiping Jia
Journal:  Mol Cell Biochem       Date:  2008-11-07       Impact factor: 3.396

9.  Correlation of enhanced thrombospondin-1 expression, TGF-beta signalling and proteinuria in human type-2 diabetic nephropathy.

Authors:  Bernd Hohenstein; Christoph Daniel; Birgit Hausknecht; Kirsten Boehmer; Regine Riess; Kerstin U Amann; Christian P M Hugo
Journal:  Nephrol Dial Transplant       Date:  2008-07-30       Impact factor: 5.992

10.  Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.

Authors:  Limei Liu; Taishan Zheng; Feng Wang; Niansong Wang; Yanyan Song; Ming Li; Lifang Li; Jiamei Jiang; Weijing Zhao
Journal:  Diabetes Care       Date:  2009-10-16       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.